The U.S. Food and Drug Administration approved Tezspire (tezepelumab-ekko; Amgen) for the add-on maintenance treatment of inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in ...

Females have a higher odds of chronic rhinosinusitis (CRS) without nasal polyps than men, according to a study published ...

Amgen and AstraZeneca's Tezspire has claimed FDA approval as a treatment for chronic rhinosinusitis with nasal polyps (CRSwNP ...

Does your nose seem to always be stuffed up? Do you have loss of taste or smell? Do you get frequent sinus infections? If so, you may have nasal polyps. Which raises the question: What exactly are ...

The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.

The nose is the subject of many sayings. A measurement could be on the nose or an object right under your nose. You may be reminded to keep your nose clean and out of another’s affairs. While often ...

Patients with chronic rhinosinusitis with nasal polyps and uncontrolled asthma experienced greater improvements in lung ...

The FDA approved tezepelumab-ekko (TEZSPIRE; AstraZeneca/Amgen) on Friday as an add-on maintenance treatment in patients aged ...

AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab -ekko) has been approved in the US for the add-on maintenance treatment of ...

Chronic rhinosinusitis is inflammation of the sinuses and nasal passages that lasts at least 12 weeks. It causes ongoing symptoms, such as stuffy nose and facial pain or pressure. Although the exact ...

Antrochoanal polyps (ACPs) are benign, solitary lesions that originate from the mucosa of the maxillary sinus and extend into the nasal cavity towards the choana. They can present with unilateral ...

The FDA on Friday approved a new biologic as add-on maintenance treatment for inadequately controlled chronic rhinosinusitis ...